Literature DB >> 6138038

Binding of somatostatin to guinea-pig pancreatic membranes: regulation by ions.

D Taparel, J P Estève, C Susini, N Vaysse, D Balas, G Berthon, E Wunsch, A Ribet.   

Abstract

Somatostatin receptors were characterized on guinea-pig pancreatic acini membranes using 125I-[Tyr11] somatostatin 14 as a radioligand. In 0.1 mM Ca2+ buffer the binding was saturable and slowly reversible, exhibiting a single class of high affinity binding sites (KD = 0.15 +/- 0.03 nM) with a maximal binding capacity (B max) of 178 +/- 18 fmol/mg protein. In 30 nM) free Ca2+ buffer, the binding was highly reversible. Affinity and B max were decreased by about 2-fold. Ca2+ exhibited an EC50 of 2.4 +/- 0.9 microM to potentiate the binding of somatostatin. Na+, but not K+, inhibited the binding: Bmax was decreased with no change in affinity. Somatostatin analogs inhibited the binding of 125I-[Tyr11] somatostatin 14. The relative potencies were: somatostatin 14 greater than somatostatin 28 = [Nle8]somatostatin 28 greater than [D Tryp8, D Cys14]somatostatin 14.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6138038     DOI: 10.1016/s0006-291x(83)80009-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes.

Authors:  M Zeggari; J P Esteve; I Rauly; C Cambillau; H Mazarguil; M Dufresne; L Pradayrol; J A Chayvialle; N Vaysse; C Susini
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

2.  Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.

Authors:  T Kadar; T W Redding; M Ben-David; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.